TP53 and neoplasm: They showed that, in 56.3% of patients with IDH1 wild-type GBM, tissue from their tumor-free SVZ contained mutations in cancer-driving genes such as the mentioned TP53, PTEN, and EGFR, that were similar to those observed at high levels in the tumor.